BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36651182)

  • 1. Re-sensitization of Multidrug-Resistant and Colistin-Resistant Gram-Negative Bacteria to Colistin by Povarov/Doebner-Derived Compounds.
    Onyedibe KI; Nemeth AM; Dayal N; Smith RD; Lamptey J; Ernst RK; Melander RJ; Melander C; Sintim HO
    ACS Infect Dis; 2023 Feb; 9(2):283-295. PubMed ID: 36651182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance and detection of plasmid mediated colistin resistance mcr-1 gene among Escherichia coli and Klebsiella pneumoniae isolated from clinical samples.
    Karki D; Dhungel B; Bhandari S; Kunwar A; Joshi PR; Shrestha B; Rijal KR; Ghimire P; Banjara MR
    Gut Pathog; 2021 Jul; 13(1):45. PubMed ID: 34225805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence Determinants and Plasmid-Mediated Colistin Resistance
    Tartor YH; Gharieb RMA; Abd El-Aziz NK; El Damaty HM; Enany S; Khalifa E; Attia ASA; Abdellatif SS; Ramadan H
    Front Cell Infect Microbiol; 2021; 11():761417. PubMed ID: 34888259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).
    Ruekit S; Srijan A; Serichantalergs O; Margulieux KR; Mc Gann P; Mills EG; Stribling WC; Pimsawat T; Kormanee R; Nakornchai S; Sakdinava C; Sukhchat P; Wojnarski M; Demons ST; Crawford JM; Lertsethtakarn P; Swierczewski BE
    BMC Infect Dis; 2022 Aug; 22(1):695. PubMed ID: 35978294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the antimicrobial resistance profiles of WHO critical priority list bacterial strains.
    Havenga B; Ndlovu T; Clements T; Reyneke B; Waso M; Khan W
    BMC Microbiol; 2019 Dec; 19(1):303. PubMed ID: 31870288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial effect of rose bengal against colistin-resistant gram-negative bacteria.
    Kurosu M; Mitachi K; Pershing EV; Horowitz BD; Wachter EA; Lacey JW; Ji Y; Rodrigues DJ
    J Antibiot (Tokyo); 2023 Jul; 76(7):416-424. PubMed ID: 37076631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 10. Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria.
    Witherell KS; Price J; Bandaranayake AD; Olson J; Call DR
    J Glob Antimicrob Resist; 2020 Sep; 22():706-712. PubMed ID: 32512236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant
    Hu Y; Liu Y; Coates A
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network.
    Garza-Ramos U; Silva-Sánchez J; López-Jácome LE; Hernández-Durán M; Colín-Castro CA; Sánchez-Pérez A; Rodríguez-Santiago J; Morfín-Otero R; Rodriguez-Noriega E; Velázquez-Acosta MD; Vázquez-Larios MDR; Feliciano-Guzmán JM; Rojas-Larios F; Ponce-De-Leon A; Lozano-Garcia M; Choy-Chang EV; López-Gutiérrez E; Molina-Jaimes A; Gil-Veloz M; Corte-Rojas RE; López-Ovilla I; Ramirez-Mis JL; Rodríguez-Balderas DE; Molina-Chavarria A; Padilla-Ibarra C; Quevedo-Ramos MA; Mireles-Dávalos CD; Rodríguez-Medina N; Rubio-Mendoza D; Córdova-Fletes C; Cruz-López F; Becerra-Montejano DA; Mercado-Longoria R; Martínez-Villarreal RT; Barlandas-Rendón NRE; Mena-Ramírez JP; Couoh-May CA; Alcaraz-Espejel M; Adame-Alvarez C; Hernández-Vicente L; Garza-González E
    Microb Drug Resist; 2023 Jun; 29(6):239-248. PubMed ID: 36595348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
    Domalaon R; Okunnu O; Zhanel GG; Schweizer F
    J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
    Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
    Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of In vitro Efficacy of Meropenem/Colistin and Meropenem/Fosfomycin Combinations on Multidrug Resistant Gram-Negative Bacilli].
    Adaleti R; Nakipoğlu Y; Arıcı N; Kansak N; Çalık Ş; Şenbayrak S; Balık R; Aksaray S
    Mikrobiyol Bul; 2023 Jul; 57(3):365-377. PubMed ID: 37462301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
    Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India.
    Manohar P; Shanthini T; Ayyanar R; Bozdogan B; Wilson A; Tamhankar AJ; Nachimuthu R; Lopes BS
    J Med Microbiol; 2017 Jul; 66(7):874-883. PubMed ID: 28671537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of antimicrobial peptide CDP-B11 alone and in combination with colistin against colistin-resistant and multidrug-resistant Escherichia coli.
    Witherell KS; Price J; Bandaranayake AD; Olson J; Call DR
    Sci Rep; 2021 Jan; 11(1):2151. PubMed ID: 33495505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.